Page last updated: 2024-11-01

niclosamide and Uterine Neoplasms

niclosamide has been researched along with Uterine Neoplasms in 1 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Uterine Neoplasms: Tumors or cancer of the UTERUS.

Research Excerpts

ExcerptRelevanceReference
"To assess the effect of three WNT/β-catenin pathway inhibitors-inhibitor of β-catenin and TCF4 (ICAT), niclosamide, and XAV939-on the proliferation of primary cultures of human uterine leiomyoma cells."3.80Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth. ( Bulun, SE; Coon V, JS; Druschitz, SA; Gottardi, CJ; Moravek, MB; Navarro, A; Ono, M; Yin, P, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ono, M1
Yin, P1
Navarro, A1
Moravek, MB1
Coon V, JS1
Druschitz, SA1
Gottardi, CJ1
Bulun, SE1

Other Studies

1 other study available for niclosamide and Uterine Neoplasms

ArticleYear
Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth.
    Fertility and sterility, 2014, Volume: 101, Issue:5

    Topics: Adult; Cell Proliferation; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds, 3-Ring;

2014